FDA Inspection
Intas Pharmaceuticals Ltd.Intas Pharmaceuticals Ltd. – FDA Inspection, Sep 16, 2025
Record Details
This FDA Inspection record concerns Intas Pharmaceuticals Ltd., with an inspection on September 16, 2025, covering drugs.
- Company
- Intas Pharmaceuticals Ltd.
- Inspection Date
- September 16, 2025
- Product Type
- Drugs
View Company Profile
ID · 566379bf-7035-4d36-bb1d-1e691aa7ea29
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1281036
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Intas Pharmaceuticals Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| January 24, 2024 | Not classified | Office of Inspections and Investigations | |
| January 20, 2023 | VAI | Office of Inspections and Investigations | |
| April 12, 2019 | Not classified | Office of Inspections and Investigations |
Other documents for Intas Pharmaceuticals Ltd.
- FDA Inspection 1228825 - 2024-01-24
- FDA Inspection 1195132 - 2023-01-20
- FDA Inspection 1089648 - 2019-04-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.